Articles

SpeeDx has significantly contributed to the success and development of the Australian MedTech industry. The CSIRO’s Medical Technologies and Pharmaceutical Roadmap, released in April, identifies Australia as being responsible for...

SpeeDx's Alison Todd frontline fighter in the war on superbugs Alison Todd co-founded SpeeDx with Elisa Mokany in 2008. The company manufactures and sells tests for detecting infectious pathogens and identifying...

The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations (MRMMs) are increasingly being reported. Key Findings 63.6% M.genitalium-positive samples indicated macrolide...

  A prospective evaluation study published in the Journal of Clinical Microbiology evaluated our ResistancePlus® MG assay against 1089 symptomatic and asymptomatic male and female urine and anogenital swab samples. Key Findings 6%...